Evidence-based recommendations on idelalisib (Zydelig) for follicular lymphoma that has not responded to 2 prior lines of treatment in adults
The guideline covers diagnosing, treating and managing epilepsy and seizures in children, young people and adults in primary and secondary care. It offers best practice advice on managing epilepsy to improve health outcomes so that people with epilepsy can fully participate in daily life.
NICE indicators. NM03 epilepsy guidance.
Everything NICE has said on diagnosing and managing non-Hodgkin's lymphoma in adults and young people 16 years and older in an interactive flowchart
Contact the Office for Market Access (OMA)
Apply for a NICE fellowship
Apply for a NICE scholarship
Access and insight for international organisations into the way we work. Learn about our products and the processes and methods we use to develop them.
There were more than 626,000 births in the NHS in 2017/18, with around 100,000 neonatal admissions to hospital each year. This report focuses on
Everything NICE has said on managing ulcerative colitis in adults, children and young people in an interactive flowchart
Everything NICE has said on severe mental illness and substance misuse (dual diagnosis) for people over 14 in community services in an interactive flowchart
Everything NICE has said on diagnosing and managing colorectal cancer in an interactive flowchart
The NICE scientific advice team
Our impact reports look at how the health and care system uses NICE's recommendations to improve people's health and care.
NICE Medicines and technologies programme: adoption team
A quick, easy way to access key information from NICE on social care topics.
How the health and care system uses our recommendations to improve outcomes in priority areas.
Evidence-based antimicrobial prescribing guidance for primary and secondary care with a focus on bacterial infection and antibiotic use.
This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with cellulitis and erysipelas. It aims to optimise antibiotic use and reduce antibiotic resistance.
Everything NICE has said on antimicrobial prescribing for cellulitis and erysipelas in an interactive flowchart
NICE has said that a new drug for preventing migraine is not a cost effective use of NHS resources, in final draft guidance published today (26 September 2019).
Operations are set to start taking place in the NHS
Regularly monitoring women who are pregnant with twins or triplets, to spot any possible complications, can lead to better outcomes for mothers and their babies, as highlighted in NICE’s impact report.
Everything NICE has said on antimicrobial prescribing for common infections in an interactive flowchart
Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart
Everything NICE has said on preventing and controlling healthcare-associated infections in an interactive flowchart
Everything NICE has said on preventing and managing pressure ulcers in all age groups in primary care and community settings in an interactive flowchart
NICE guidelines are evidence-based recommendations for health and care in England.
1 Abortion before 14 weeks: choosing between medical or surgical abortion Decision aid c NICE 2019. All rights reserved. Subject to Notice of rights.
1 Abortion from 14 weeks up to 24 weeks: choosing between medical or surgical abortion Decision aid c NICE 2019. All rights reserved. Subject to...
Evidence-based recommendations on bioprosthetic plug insertion for anal fistula in adults
Evidence-based recommendations on high-intensity focused ultrasound for glaucoma in adults
NICE is unable to make a recommendation about the use in the NHS of lenalidomide (Revlimid) with bortezomib and dexamethasone for untreated multiple myeloma
NICE is unable to make a recommendation about the use in the NHS of pomalidomide (Imnovid) with bortezomib and dexamethasone for relapsed or refractory myeloma
NICE is unable to make a recommendation about the use in the NHS of bezlotoxumab (Zinplava) for preventing recurrent Clostridium difficile infection in adults
Part of NICEimpact maternity and neonatal care Previous: Spotlight on valproate prescribing Dr Kathryn Gutteridge, President of The
Part of NICEimpact maternity and neonatal care Previous: Specialist care of newborns Next: Commentary Babies exposed to valproate
Part of NICEimpact maternity and neonatal care Previous: Maternity and mental health Next: Spotlight on valproate prescribing
Part of NICEimpact maternity and neonatal care Previous: Updates from our last maternity report Next: Specialist care of newborns
Part of NICEimpact maternity and neonatal care Previous: Introduction Next: Maternity and mental health In May 2018 we published
Deborah Duval, the editor of Kidney Matters magazine, tells us how we can enjoy food even on a restricted renal diet
On this page: Who we are and what we do What we spend and how we spend it What are our priorities and how are we doing? How we make decisions Our
Outside interests of the NICE board
Everything NICE has said on identifying, treating and managing depression in children, young people and adults in an interactive flowchart
We produce guidance and quality standards to help reduce health inequalities, to improve access to healthcare and to encourage health improvement. We
This guideline covers care for women of any age (including girls and young women under 18) who request an abortion. It aims to improve the organisation of services and make them easier for women to access. Detailed recommendations on conducting abortions at different gestational stages are also included, to ensure that women get the safest and most effective care possible.
Everything NICE has said on abortion care in an interactive flowchart.
Everything NICE has said on managing twin and triplet pregnancies in the antenatal and intrapartum period in an interactive flowchart
Share Share Linked In Twitter